Impact of Tumor Characteristic on the Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma

被引:30
|
作者
Dudek, K.
Kornasiewicz, O.
Remiszewski, P.
Kobryn, K. [1 ]
Ziarkiewicz-Wroblewska, B. [2 ]
Gornicka, B. [2 ]
Zieniewicz, K.
Krawczyk, M.
机构
[1] Med Univ Warsaw 1A, Dept Gen Transplant & Liver Surg, Students Sci Grp, Warsaw, Poland
[2] Med Univ Warsaw 1A, Dept Pathol, Warsaw, Poland
关键词
PREDICTING RECURRENCE; DIFFERENTIATION; RESECTION; SURVIVAL; INVASION; HCC;
D O I
10.1016/j.transproceed.2009.08.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Orthotopic liver transplantation (OLT) is a well-established treatment for cirrhotic patients with hepatocellular carcinoma (HCC) who meet the Milan criteria. The aim of this study was to identify predictors of survival among 65 patients with HCC in cirrhotic livers who underwent liver transplantation (OLT). Methods. From January 2001 to December 2008, we performed 655 OLT in 615 patients. HCC was diagnosed in 58 patients before OLT and in 65 by histological examination of the explanted livers; 74% of the patients met Milan criteria by histological examination. Results. The median follow-up was 27 months (range = 1-96). We analyzed patient age and gender, etiology of liver disease, Child score at transplantation, rejection episodes, tumor number/size, vascular invasion, and differentiation grade. There was no significant difference in survival among patients grouped according to the Model for End-stage Liver Disease staging system for HCC. The 5-year survival of patients with low differentiated (G3) HCC was significantly worse than that of those with moderately differentiated (G2) or well-differentiated (G1) HCC: 50%, 81%, and 86% respectively, (P < .01). Patients with microvascular invasion displayed a worse 5-year survival than those without vascular invasion (42% vs 80%; P < .01). Conclusions. The analysis indicated that the histological grade of the tumors and evidences of microscopic vascular invasion were the most useful predictive factors for overall survival among patients with cirrhosis after liver transplantation for HCC.
引用
收藏
页码:3135 / 3137
页数:3
相关论文
共 50 条
  • [21] Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation
    Guerrero-Misas, Marta
    Rodriguez-Peralvarez, Manuel
    De la Mata, Manuel
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (04) : 649 - 661
  • [22] Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation
    Marta Guerrero-Misas
    Manuel Rodríguez-Perálvarez
    Manuel De la Mata
    World Journal of Hepatology, 2015, (04) : 649 - 661
  • [23] Outcome of cirrhotic patients with incidental hepatocellular carcinoma undergoing liver transplantation
    Charco, R
    Hidalgo, E
    Lázaro, JL
    Vargas, V
    Castells, L
    Murio, E
    Bilbao, I
    Margarit, C
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 299 - +
  • [24] Survival outcome after liver transplantation in US patients with hepatocellular carcinoma
    Ismail, Mohamed Saleh
    Hassan, Manal
    Dawood, Lydia
    Patel, Kalpesh
    Jalal, Prasun
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E561 - E561
  • [25] Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation
    Kishi, Yoji
    Sugawara, Yasuhiko
    Tamura, Sumihito
    Kaneko, Junichi
    Kokudo, Norihiro
    Makuuchi, Masatoshi
    TRANSPLANT INTERNATIONAL, 2006, 19 (09) : 720 - 725
  • [26] Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation - Invited response
    Tamura, S
    Kato, T
    Reddy, R
    Tzakis, A
    ARCHIVES OF SURGERY, 2001, 136 (01) : 31 - 31
  • [27] Efficacy of Tumor Markers After Liver Transplantation In Patients With Hepatocellular Carcinoma
    Lee, Tae Yun
    Choi, Ho Joong
    Ahn, Joseph
    Hong, Tae Ho
    You, Young-Kyoung
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 461 - 467
  • [28] The Impact of Time Interval between Hepatic Resection and Liver Transplantation on Clinical Outcome in Patients with Hepatocellular Carcinoma
    Serenari, Matteo
    Prosperi, Enrico
    Allard, Marc-Antoine
    Paterno, Michele
    Golse, Nicolas
    Laurenzi, Andrea
    Adam, Rene
    Ravaioli, Matteo
    Cherqui, Daniel
    Cescon, Matteo
    CANCERS, 2021, 13 (10)
  • [29] Predictive factors of outcome after liver transplantation in patients with liver cirrhosis and hepatocellular carcinoma
    Merli, M
    Nicolini, G
    Gentile, F
    Indrio, G
    Iappelli, M
    Rossi, M
    Berloco, P
    Di Tondo, U
    Muda, AO
    Corradini, SG
    Nudo, F
    Attili, AF
    GASTROENTEROLOGY, 2004, 126 (04) : A703 - A704
  • [30] Liver transplantation for patients with hepatocellular carcinoma
    Ho, MC
    Wu, YM
    Hu, RH
    Ko, WJ
    Yang, PM
    Lai, MY
    Lin, MH
    Lin, HY
    Lee, PH
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (08) : 2291 - 2292